Sath Shukla - Aug 2, 2024 Form 4 Insider Report for Spero Therapeutics, Inc. (SPRO)

Role
CEO and President
Signature
/s/ Sath Shukla
Stock symbol
SPRO
Transactions as of
Aug 2, 2024
Transactions value $
-$42,646
Form type
4
Date filed
8/6/2024, 07:56 PM
Previous filing
Feb 5, 2024
Next filing
Aug 29, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SPRO Common Stock Sale -$19.5K -14.8K -1.26% $1.32 1.16M Aug 2, 2024 Direct F1
transaction SPRO Common Stock Sale -$23.1K -17.6K -1.52% $1.31 1.14M Aug 5, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction is a sale of common stock effected to cover tax withholding obligations in connection with the vesting of RSUs that were granted to the Reporting Person on August 1, 2023 pursuant to a "sell to cover" provision included in each RSU Agreement.